Comprehensive Analysis of Proteinuria and Nephrotic Syndrome Using the Japanese Adverse Drug Event Reporting Database
These findings suggest that anti-VEGF agents play a significant role in the development of proteinuria and NS. Given the widespread use of anti-VEGF therapy, heightened vigilance, routine monitoring, and timely interventions are crucial to mitigate these risks and improve patient outcomes.
Authors
- Kennosuke Yorifuji
- Kenta Yamaoka
- Sho Masago
- Yoshihiro Uesawa (ORCID: https://orcid.org/0000-0002-5773-991X)
- Tadashi Shimizu (ORCID: https://orcid.org/0000-0002-5563-6730)
- Mayako Uchida (ORCID: https://orcid.org/0000-0003-0507-7309)
Institutions
- Meiji Pharmaceutical University (JP)
- Kyushu University Hospital (JP)
- Shinko Hospital (JP)
- Kobe City Medical Center General Hospital (JP)
- Kobe University (JP)
Publication Details
- Journal
- In Vivo
- Published
- 2025-06-27
- DOI
- https://doi.org/10.21873/invivo.14002
- Primary Topic
- Statistical Methods in Clinical Trials
- Type
- article
- Field-Weighted Citation Impact
- 0.00